Evidence map›Paper›PMID 30455460›Full record

ArticleNature immunology2019

Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii.

Alexandra Safronova, Alessandra Araujo, Ellie T Camanzo, Taylor J Moon, Michael R Elliott, Daniel P Beiting, Felix Yarovinsky

Open access · greenAbstract read
In one paragraph

Article in Nature immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 1 synthesis or guideline pooled it, 88 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Protozoan-Derived Cytokine-Transgenic Macrophages Reverse Hepatic Fibrosis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  18. Article
  19. Heliyon · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Alexandra SafronovaCenter for Vaccine Biology and Immunology, Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY, USA.
Alessandra AraujoCenter for Vaccine Biology and Immunology, Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY, USA.
Ellie T CamanzoCenter for Vaccine Biology and Immunology, Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY, USA.
Taylor J MoonCenter for Vaccine Biology and Immunology, Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY, USA.
Michael R ElliottCenter for Vaccine Biology and Immunology, Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY, USA.
Daniel P BeitingDepartment of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Felix YarovinskyCenter for Vaccine Biology and Immunology, Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY, USA. felix_yarovinsky@urmc.rochester.edu.ORCID http://orcid.org/0000-0001-5825-8002
University of Rochester Medical Center · USUniversity of Pennsylvania · US

Funding

Mucosal immunity to Toxoplasma gondiiR01AI136538 · NIAID · UNIVERSITY OF ROCHESTER · PI Felix Yarovinsky · 2018 to 2026
$4.0M
Neutrophil IFN-gamma in host defense and inflammationR01AI121090 · NIAID · UNIVERSITY OF ROCHESTER · PI YAROVINSKY, FELIX · 2016 to 2020
$2.3M
NIAID NIH HHS R01 AI121090NIAID NIH HHS R01 AI136538
6 · The paper itself

Abstract

Toxoplasma gondii is a common protozoan parasite that infects up to one third of the world's population. Notably, very little is known about innate immune sensing mechanisms for this obligate intracellular parasite by human cells. Here, by applying an unbiased biochemical screening approach, we show that human monocytes recognized the presence of T. gondii infection by detecting the alarmin S100A11 protein, which is released from parasite-infected cells via caspase-1-dependent mechanisms. S100A11 induced a potent chemokine response to T. gondii by engaging its receptor RAGE, and regulated monocyte recruitment in vivo by inducing expression of the chemokine CCL2. Our experiments reveal a sensing system for T. gondii by human cells that is based on the detection of infection-mediated release of S100A11 and RAGE-dependent induction of CCL2, a crucial chemokine required for host resistance to the parasite.

Indexed as

Immunity, InnateAnimalsAntigens, NeoplasmCaspase 1Chemokine CCL2ChemotaxisHumansMiceMice, Inbred C57BLMice, KnockoutMitogen-Activated Protein KinasesRNA, Small InterferingS100 ProteinsTHP-1 CellsToxoplasmaToxoplasmosisAntigens, NeoplasmCaspase 1Chemokine CCL2Mitogen-Activated Protein KinasesMOK protein, humanRNA, Small InterferingS100A11 protein, mouseS100 Proteins

Identifiers

PMID30455460
PMCPMC6291348
OpenAlexW2900675224

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.